Drug Shortage Report for COZAAR
| Report ID | 113155 |
| Drug Identification Number | 02182882 |
| Brand name | COZAAR |
| Common or Proper name | losartan potassium tablets |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LOSARTAN POTASSIUM |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-04-24 |
| Actual start date | 2020-04-24 |
| Estimated end date | 2020-05-01 |
| Actual end date | 2020-04-28 |
| Shortage status | Resolved |
| Updated date | 2020-04-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-04-29 | English | Compare |
| v5 | 2020-04-28 | French | Compare |
| v4 | 2020-04-28 | English | Compare |
| v3 | 2020-04-25 | English | Compare |
| v2 | 2020-04-24 | French | Compare |
| v1 | 2020-04-24 | English | Compare |
Showing 1 to 6 of 6